medroxyprogesterone acetate
- RxCUI
- 1000112
- RxNorm name
- medroxyprogesterone acetate
- Term type
- PIN
- Status
- Active
- Updated
- 2026-10-21 00:27:13
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092010
- Active start
- 092010
- Multiple ingredient
- NO
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| medroxyprogesterone | 6691 |
Source Vocabulary Codes#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Coupler LLC | 2cf48919-6de8-d3d0-e063-6394a90ac1bc | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate Injectable Suspension | MEDROXYPROGESTERONE ACETATE | Hikma Pharmaceuticals USA Inc. | 0476eac5-d96c-4910-aa86-1ddeeefefe50 | 2025-01-08 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | PD-Rx Pharmaceuticals, Inc. | 437edd12-2c08-4df4-8cf7-64c47e4779ac | 2025-01-02 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Bryant Ranch Prepack | a36c89b7-9463-4d00-a4d3-021d77090077 | 2024-07-08 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Bryant Ranch Prepack | a88b33ff-842b-4a5b-a27e-9c2b9e85a4d7 | 2024-07-08 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Bryant Ranch Prepack | bdb89690-ced2-48e1-bb1a-e5eccfeda8eb | 2024-07-08 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Bryant Ranch Prepack | d9ad130b-8f9a-4a0f-beb4-b692b6d3c5ca | 2024-07-08 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | NuCare Pharmaceuticals,Inc. | 5c8ffae3-3b3e-197e-e053-2a91aa0a59e3 | 2024-06-04 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Teva Pharmaceuticals USA, Inc. | 9eb200b0-db96-4a51-87ea-04db862978c8 | 2024-03-01 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| medroxyprogesterone acetate | MEDROXYPROGESTERONE ACETATE | A-S Medication Solutions | ca344c55-5251-470f-9243-eceb9e496e3e | 2023-10-23 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Proficient Rx LP | 0df6fd1e-7d9c-4a38-848c-1e562e211c91 | 2023-02-01 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| MEDROXYPROGESTERONE ACETATE | MEDROXYPROGESTERONE ACETATE | Sun Pharmaceutical Industries, Inc. | 01e28bef-9758-40cf-a4ff-86ae9f4f5105 | 2022-12-14 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| MEDROXYPROGESTERONE ACETATE | MEDROXYPROGESTERONE ACETATE | Sun Pharmaceutical Industries, Inc. | d1ea4098-6196-421f-b8e1-bcb31a061e04 | 2021-06-29 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Mylan Institutional LLC | 60aba812-59eb-4d40-9b6b-d135dca9d36b | 2021-03-12 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | G03DA | Pregnen (4) derivatives | ATC1-4 | medroxyprogesterone | |
| ATC | L02AB | Progestogens | ATC1-4 | medroxyprogesterone | |
| ATC | G03AC | Progestogens | ATC1-4 | medroxyprogesterone | |
| ATC | G03AA | Progestogens and estrogens, fixed combinations | ATC1-4 | estradiol / medroxyprogesterone | |
| FDASPL | D045167 | Progesterone Congeners | CHEM | has_chemical_structure | medroxyprogesterone |
| FDASPL | N0000175602 | Progestin | EPC | has_epc | medroxyprogesterone |
| MEDRT | D008525 | Medroxyprogesterone | CHEM | has_ingredient | medroxyprogesterone |
| MEDRT | D017258 | Medroxyprogesterone Acetate | CHEM | has_ingredient | medroxyprogesterone acetate |
| MEDRT | D000568 | Amenorrhea | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D000568 | Amenorrhea | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D002292 | Carcinoma, Renal Cell | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D002292 | Carcinoma, Renal Cell | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D002543 | Cerebral Hemorrhage | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D002543 | Cerebral Hemorrhage | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D004714 | Endometrial Hyperplasia | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D004714 | Endometrial Hyperplasia | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D016889 | Endometrial Neoplasms | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D016889 | Endometrial Neoplasms | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D006470 | Hemorrhage | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D006470 | Hemorrhage | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D007040 | Hypoventilation | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D007040 | Hypoventilation | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D009376 | Neoplasms, Hormone-Dependent | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D009376 | Neoplasms, Hormone-Dependent | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D011247 | Pregnancy | DISEASE | may_prevent | medroxyprogesterone |
| MEDRT | D011247 | Pregnancy | DISEASE | may_prevent | medroxyprogesterone acetate |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D011655 | Pulmonary Embolism | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D011655 | Pulmonary Embolism | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D013924 | Thrombophlebitis | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D013924 | Thrombophlebitis | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D014623 | Vaginal Diseases | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D014623 | Vaginal Diseases | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D020246 | Venous Thrombosis | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D020246 | Venous Thrombosis | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | N0000000185 | Progestational Hormone Receptor Agonists | MOA | has_moa | medroxyprogesterone |
| MEDRT | N0000000185 | Progestational Hormone Receptor Agonists | MOA | has_moa | medroxyprogesterone acetate |
| MEDRT | N0000008630 | Decreased Follicle Stimulating Hormone Secretion | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000008630 | Decreased Follicle Stimulating Hormone Secretion | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000008632 | Decreased Growth Hormone Secretion | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000008632 | Decreased Growth Hormone Secretion | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009051 | Gonadotropin Releasing Hormone Alteration | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009051 | Gonadotropin Releasing Hormone Alteration | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009715 | Inhibit Ovarian Follicular Phase | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009715 | Inhibit Ovarian Follicular Phase | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009717 | Inhibit Ovulation | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009717 | Inhibit Ovulation | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009857 | Stimulate Breast Glandular Development | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009857 | Stimulate Breast Glandular Development | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000000043 | Hepatic Excretion | PK | has_pk | medroxyprogesterone |
| MEDRT | N0000000043 | Hepatic Excretion | PK | has_pk | medroxyprogesterone acetate |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | medroxyprogesterone |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | medroxyprogesterone acetate |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | medroxyprogesterone |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | medroxyprogesterone acetate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| CODES | DRUGBANK | DB00603 |
| CODES | SNOMEDCT | 126112002 |
| CODES | USP | m47910 |
| CODES | VUID | 4017828 |
| NAMES | Tallman Synonym | medroxyPROGESTERone acetate |
| SOURCES | Source | Drug Bank |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | United States Pharmacopeia |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |